Hematology

Introduction and Analysis MethodologyClinical Context

Unfractionated Heparin (UFH)Parenteral Anticoagulants

Enoxaparin Sodium (LMWH)Parenteral Anticoagulants

Fondaparinux SodiumParenteral Anticoagulants

Warfarin Sodium / AcenocoumarolOral Anticoagulants

Rivaroxaban / ApixabanDirect Acting Oral Anticoagulants (DOACs)

Dabigatran EtexilateDirect Acting Oral Anticoagulants (DOACs)

Acetylsalicylic acid (AAS)Antiplatelet Agents

ClopidogrelAntiplatelet Agents

Ticagrelor / PrasugrelAntiplatelet Agents

Glycoprotein IIb/IIIa Inhibitors (Abciximab / Tirofiban)Antiplatelet Agents

Alteplase (rt-PA) / TenecteplaseFibrinolytics

Tranexamic AcidAntifibrinolytics

Erythropoietic Agents (Epoetin Alfa / Darbepoetin)Hematopoietic Growth Factors

Colony Stimulating Factors (Filgrastim / Pegfilgrastim)Hematopoietic Growth Factors

Thrombopoietin analogues (Romiplostim / Eltrombopag)Hematopoietic Growth Factors

Factor Replacement Therapies (Factor VIII / Factor IX)Coagulation Factors

EmicizumabImmunotherapy in Hemostasis

Idarucizumab / Andexanet AlfaAntidotes and Reversers

Deferasirox / DeferoxamineIron Chelators

Synthesis and Summary of Hematological MonitoringIntegration and Advanced Review